SuperworthOrganon profit margin OGN
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- 3.4%
- Operating margin, 12 months
- 13.4%
- Net margin on a year earlier
- −7.7 pts
- Peer median
- 17.2%
Over the twelve months to Jun 30, 2026, Organon kept 3.4% of its revenue as net profit, with an operating margin of 13.4% and a gross margin of 52.7%.
Five years earlier its net margin was 27.5%.
The median for 10 large drugmakers of a similar size is 17.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 3.0% | 13.3% | 53.3% |
| FY2024 | 13.5% | 21.5% | 58.0% |
| FY2023 | 16.3% | 20.1% | 59.8% |
| FY2022 | 14.9% | 25.4% | 62.8% |
| FY2021 | 21.4% | 28.7% | 62.2% |
| FY2020 | 33.1% | 42.7% | 67.6% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 3.4% | −7.7 pts | 13.4% | |
| Q1 FY26 | 4.0% | −7.9 pts | 13.4% | |
| Q4 FY25 | 3.0% | −10.5 pts | 13.3% | |
| Q3 FY25 | 8.0% | −12.3 pts | 19.1% | |
| Q2 FY25 | 11.1% | −4.6 pts | 18.9% | |
| Q1 FY25 | 11.9% | −4.6 pts | 19.6% | |
| Q4 FY24 | 13.5% | −2.8 pts | 21.5% | |
| Q3 FY24 | 20.3% | +10.8 pts | 20.9% | |
| Q2 FY24 | 15.8% | +3.5 pts | 19.4% | |
| Q1 FY24 | 16.5% | +4.4 pts | 19.7% | |
| Q4 FY23 | 16.3% | +1.5 pts | 20.1% | |
| Q3 FY23 | 9.5% | −6.6 pts | 20.6% |
Against its peers
Companies in Drug Manufacturers - General nearest Organon's size, closest first, today.
| Company | Profit margin |
|---|---|
| OGNOrganon | 3.4% |
| LQDALiquidia | 30.7% |
| ARQTArcutis Biotherapeutics | 6.1% |
| INDVIndivior Pharmaceuticals | 26.7% |
| NRIXNurix Therapeutics | 42.0% |
| PBHPrestige Consumer Healthcare | 15.6% |
| KNSAKiniksa Pharmaceuticals International | 9.6% |
| LGNDLigand Pharmaceuticals | 67.9% |
| HRMYHarmony Biosciences | 18.9% |
| AMRXAmneal Pharmaceuticals | 5.0% |
| ALKSAlkermes plc. | 4.0% |
| Peer median | 17.2% |
Where Organon ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Organon
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.